［1］Benn P,Cuckle H,Pergament E.Non-invasive prenatal testing for aneuploidy:current status and future prospects［J］.Ultrasound Obstet Gynecol,2013,42(1):15-33.
［2］潘慧，班博，于萍，等.从临床诊疗指南及专家共识角度看重组人生长激素治疗的规范化应用［J/CD］.中华诊断学电子杂志，2014，2（2）：85-89.
［3］赵晓曦.无创性产前诊断胎儿染色体异常的研究进展［J］.中华妇幼临床医学杂志，2010，6(5) :370-372.
［4］刘红彦，吴东,李慧.孕妇血浆胎儿游离DNA检测对胎儿染色体拷贝数异常的诊断意义［J］.中华医学遗传学杂志,2012,29(4):435-438.
［5］赵晓曦，苏日娜，谷孝月，等.无创产前基因检测技术在临床应用价值［J/CD］.中华临床医师杂志（电子版），2013,7（23）：284-287.
［6］Song K,Musci TJ,Caughey AB.Clinical utility and cost of non-invasive prenatal testing with cfDNA analysis in high-risk women based on a US population［J］.J Matern Fetal Neonatal Med,2013,26(12):1180-1185.
［7］Baffero GM,Somigliana E,Crovetto F.Confined placental mosaicism at chorionic villous sampling:risk factors and pregnancy outcome［J］.Prenat Diagn,2012,32(11):1102-1108.